Integrating Best Practices to Improve Outcomes in Relapsed/Refractory Multiple Myeloma

Amy E. Pierre, MSN, ANP-BC, and Joshua Richter, MD, break down the approved and emerging treatment options for relapsed/refractory multiple myeloma, including mechanisms of action, supporting clinical data, and associated adverse events, and discuss best practices for selecting and sequencing therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Pierre, Amy E., Richter, Joshua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2020
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857318/
https://www.ncbi.nlm.nih.gov/pubmed/33598331
http://dx.doi.org/10.6004/jadpro.2020.11.3.18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857318/
https://www.ncbi.nlm.nih.gov/pubmed/33598331
http://dx.doi.org/10.6004/jadpro.2020.11.3.18

Ejemplares similares